SCHEMBL4128997

SCHEMBL4128997

COc1c(C=C2SC(Nc3ccc(CC(=O)O)cc3)=NC2=O)ccc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.40
PDE4B Q07343 4/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGER4 P35408 1/20 0.39
NR1H4 Q96RI1 2/20 0.39
POLB P06746 2/20 0.38
GLA P06280 1/20 0.38
KMT2A Q03164 1/20 0.38
FABP4 P15090 1/20 0.37
AKR1B1 P15121 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128994 1.00 ALOX5 (0.40) ALOX5PDE4BALDH1A1MAPTHTT
SCHEMBL4634765 0.85 ALOX5 (0.52) ALOX5PDE4BALDH1A1MAPTHTT
SCHEMBL4634758 0.85 ALOX5 (0.52) ALOX5PDE4BALDH1A1MAPTHTT
SCHEMBL4133059 0.85 KMT2A (0.44) ALOX5ALDH1A1MAPTHTTKDM4E
SCHEMBL4122284 0.80 PDE4B (0.42) ALOX5PDE4BALDH1A1MAPTKDM4E
SCHEMBL4122280 0.80 PDE4B (0.42) ALOX5PDE4BALDH1A1MAPTKDM4E
Acetic Acid SCHEMBL4669507 0.79 ALDH1A1 (0.40) ALOX5ALDH1A1MAPTHTTKDM4E
Acetic Acid SCHEMBL4143413 0.79 ALDH1A1 (0.40) ALOX5ALDH1A1MAPTHTTKDM4E
SCHEMBL4137321 0.79 NR1H4 (0.41) PDE4BALDH1A1MAPTHTTKDM4E
SCHEMBL4137317 0.79 NR1H4 (0.41) PDE4BALDH1A1MAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ ALOX5 3505/4885PDE4B 161/4885ALDH1A1 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.